Pranay Parab is an independent tech journalist based in Mumbai, India. He covers tech for Lifehacker, and specializes in tutorials and in-depth features. How to sign up for the Affinity free trial ...
CyPath® Lung unit sales in April increased nearly 300% compared to April 2025Increasing unit sales for CyPath® Lung continues first quarter 2026 trend of accelerating adoption and clinical ...
Record CyPath® Lung Revenue and Unit Sales. Revenue from our noninvasive diagnostic for lung cancer increased 87% over 2024 with the number of tests performed rising 99% year over year, reflecting ...
Apple's M1 Max GPU seems to be a better graphics card compared to AMD Radeon Pro W6900X, according to a recent benchmark experiment conducted by Affinity. The dedicated chip will come soon for the ...
SAN ANTONIO, May 08, 2026--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need ...
SAN ANTONIO, Texas--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (BIAF) (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, ...
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF and BIAFW) today announced it has entered into a securities purchase agreement with institutional investors for the purchase ...
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW) a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today ...
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results